Novartis AG (NVS) Shareholder/Analyst Call Prepared Remarks Transcript
Source: SeekingAlpha
2026-03-06 14:45:54 ET
Novartis AG (NVS) Shareholder/Analyst Call March 6, 2026 4:00 AM EST
Company Participants
Giovanni Caforio
Vasant Narasimhan - Chief Executive Officer
Charlotte Pamer-Wieser - Corporate Secretary
Simon Moroney
Charles Swanton
Harry Kirsch - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Novartis AG (NVS) Shareholder/Analyst Call Prepared Remarks Transcript
Novartis Ag Basel Akt
NASDAQ: NVSEF
NVSEF Trading
-6.09% G/L:
$158 Last:
268 Volume:
$158 Open:
NVSEF Latest News
February 25, 2026 07:00:00 am
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next?generation treatments to patients
February 06, 2026 12:00:00 pm
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
January 09, 2026 10:30:00 am
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
December 12, 2025 07:00:00 am
Novartis breaks ground on flagship manufacturing hub in North Carolina
NVSEF Stock Data
$299,675,221,187
2,118,043,712
N/A
1352
N/A
Pharmaceuticals
Healthcare
CH
Basel
